{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-057985","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.448529+00:00","generated_at":"2026-06-02T19:51:08.406454+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"TriSalus Life Sciences appoints Liselotte Hyveled to Board, effective May 6","bullets":["Board size increased to ten directors; Hyveled appointed as Class I director, term expiring at 2024 annual meeting.","Annual cash retainer of $50,000 for Board service; grant of option to purchase 35,000 shares vesting over three years.","Additional $7,500 annual retainer for each of Nominating Committee and Science & Technology Committee membership.","No arrangements or transactions requiring disclosure under Item 404(a); standard indemnity agreement entered."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-057985","json":"https://secwatch.observer/filing/0001104659-24-057985.json","markdown":"https://secwatch.observer/filing/0001104659-24-057985.md","text":"https://secwatch.observer/filing/0001104659-24-057985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/0001104659-24-057985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/tm2413673d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:51:08.406454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}